As anticipated by a recent study by Grand View Research, the global low temperature sterilization market is predicted to hit USD 5.07 Billion by 2030, further expanding at a Compound Annual Growth Rate (CAGR) of 10.99% from 2025 to 2030. A key driver backstopping this burgeoning market growth is the escalating occurrence of Healthcare-acquired Infections (HAIs). These infections amplify the necessity for effective sterilization of medical instruments like thermometers and endoscopes, employing low-temperature sterilization solutions.
As revealed by World Health Organization (WHO) data from May 2022, 15 patients out of every 100 in hospitals in low- and middle-income countries and 7 in high-income nations will contract at least one HAI during their hospital stay. Moreover, fatalities caused by HAIs affect on average, 1 in 10 patients. This alarming increase in HAIs is projected to not only amplify focus on infection control and prevention but also spur the utilisation and subsequent demand for low-temperature sterilization techniques.
Among the specific sterilization methods, vaporized hydrogen peroxide sterilization is expected to enjoy burgeoning popularity, augmented by supportive government regulations thereby augmenting the market for low-temperature sterilizers deploying this technique. Crucially, in January 2024, the Food and Drug Administration (FDA) approved the use of Vaporized Hydrogen Peroxide (VHP) – a low-temperature sterilization technique – to sterilize medical devices. This decidedly bolstered the widespread adoption of VHP in the medical industry and is envisaged to further fuel market expansion in the future.
Technological advancements are also anticipated to drive market growth, examples being the production of Poladus 150 low-temperature sterilization system by Getinge in March 2024. One significant feature includes advanced cross-contamination barrier technology and HAII prevention, among others, thereby improving device traceability and connectivity. Based on product type, the ethylene oxide sterilizers segment held the largest market share exceeding 50.01% in 2024 due to its effectiveness in sterilizing a broad array of heat- and moisture-sensitive medical devices making it a quintessential sterilization solution.
The hydrogen peroxide sterilizers segment, on the other hand, is anticipated to grow at the fastest CAGR in the forecast period. Regarding regional performance, North America leads the low-temperature sterilization market attributable to advanced healthcare infrastructure, strict regulatory protocols, and an escalating demand for infection control measures in hospitals and healthcare facilities.
Source: https://www.grandviewresearch.com/press-release/global-low-temperature-sterilization-market